Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19Show full item record
|Title||Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19|
|Author||Khimani F.; Wolf A. J.; Yoon B.; Blancke A.; Gerhart C.; Endsley D.; Dougherty A.; Ray A. K.; Yango A. F.; Flynn S. D.; Lip G. Y. H.; Gonzalez S. A.; Sathyamoorthy M.|
|Abstract||Thrombosis is a known complication of SARS-CoV-2 infection, particularly within a severely symptomatic subset of patients with COVID-19 disease, in whom an aggressive host immune response leads to cytokine storm syndrome (CSS). The incidence of thrombotic events coinciding with CSS may contribute to the severe morbidity and mortality observed in association with COVID-19. This review provides an overview of pharmacologic approaches based upon an emerging understanding of the mechanisms responsible for thrombosis across a spectrum of COVID-19 disease involving an interplay between immunologic and pro-thrombotic events, including endothelial injury, platelet activation, altered coagulation pathways, and impaired fibrinolysis. ¿ 2022|
|Department||Burnett School of Medicine|
|Subject||Anti-thrombotics in COVID-19
Anticoagulation in COVID-19
Deep vein thrombosis in COVID-19
Pulmonary embolism in COVID-19
This item appears in the following Collection(s)
- Research Publications 
Showing a few items related by title, author, creator and subject.
Saucedo, Victoria (2022-12-18)Governments responding to the 2020 coronavirus pandemic have forced billions of people around the world to stay at home and reduce the number of social interactions to stop the spread of the virus. While a multitude of ...
Lansford, Jake (2020)Stakeholders such as company management, shareholders, creditors, advisors, and employees are dependent on the success of the oil and gas exploration and production industry. The industry is a strong provider of jobs for ...
Wolf A.; Khimani F.; Yoon B.; Gerhart C.; Endsley D.; Ray A.K.; Yango A.F.; Flynn S.D.; Lip G.Y.H.; Gonzalez S.A.; Sathyamoorthy M. (2022)It is now well established that infection with SARS-CoV-2 resulting in COVID-19 disease includes a severely symptomatic subset of patients in whom an aggressive and/or dysregulated host immune response leads to cytokine ...